Windhover Information Inc. - Windhover's Update

Windhover.com | Medtech Insight | The RPM Report | Inteleos | FDC Reports

Subscriber Username: Password:

Search Articles: Advanced Search

Home

About Us

Publications

Databases

Conferences

Article Search

The IN VIVO Blog

Company Profiles

Help

Receive Windhover's unique market insight fast with our free alert service 'Windhover's Update', including the latest abstracts and summaries from:

• IN VIVO
• Start-Up
• The RPM Report
• Medtech Insight

Sign up now

Receive Windhover's Unique Market Insight Fast with 'Windhover's Update': Our Free E-mail Alert Service

Sign up to receive Windhover's Update and you'll receive free abstracts of the latest competitive, strategic, technology, and deals analysis from Windhover's leading health care business publications:

	IN VIVO: The Business and Medicine Report
	Start-Up: Windhover's Review of Emerging Medical Ventures
	The RPM Report: Regulation • Policy • Market Access
	Medtech Insight Newsletter: Medical Technology Market Intelligence

You can also receive the latest Windhover article abstracts via RSS feed.

Subscription Form * Please complete the required fields
Email Address:*

First Name:*

Last Name:*

Company Name:*

Title:*

FDA/CMS Summit
December 4-5, 2008 · Washington, DC

In³ West
March 2-4, 2009 · Las Vegas, NV

Pharmaceutical Strategic Outlook
April 13-15, 2009 · New York, NY

Interested in presenting at a Windhover conference?
Submit your idea here

Complete Conference Calendar

Can Big Pharma Save Biotech Investors?
All the biotech stock indices are down; record numbers of companies are selling at lower-than-cash valuations. Investors . . . [MORE . . .] (IN VIVO)

Will Simpler Devices Tap the Largest Diabetes Market?
The clinical community and the medical device industry are finally turning their attention to the majority of patients with . . .[MORE. . .] (Start-Up)

New Technologies Help Hospitals Tackle Patient Safety Push
CMS continues to tighten its rules on so-called "never events" - conditions acquired during hospitalization - in an ongoing . . .[MORE. . .] (Medtech Insight)

Treat and Trade: The New Priority Review Voucher Market
Starting in September, pharmaceutical companies will have the opportunity to buy the right to a faster FDA review on the . . . [MORE. . .] (The RPM Report)

Read more from this month's: IN VIVO, Start-Up, The RPM Report, and Medtech Insight.

Publications - Databases - Conferences - About Us - Contact Us - Help - The IN VIVO Blog - Company Profiles - Subscriber Login